In a spontaneous mouse model of type 1 diabetes (nonobese diabetic [NOD] mice), a half-year-long administration of anti-VAP-1 antibodies postpones the development of diabetic hyperglycemia (94). The gene discussed is AOC3; the disease is type 1 diabetes mellitus.